# Classification ACMG
#moleculaire

| Classe            | Critère 1                    | AND one of |  
|-------------------|------------------------------|--------------------------|
| Pathogenic        | 1 Very strong                | ≥1 Strong  
|                   |                              | ≥2 Moderate 
|                   |                              | 1 Moderate and 1 supporting
|                   |                              | ≥2 Supporting 
|                   |   ≥2 Strong                  | 
|                   |  1 Strong                    | ≥3 Moderate  
|                   |                              | 2 Moderate  AND ≥2 Supporting  
|                   |                              | 1 Moderate  AND ≥4 supporting 
| Likely pathogenic |  1 Very strong               | 1 moderate  
|                   |  1 Strong                    | 1–2 moderate  
|                   |  1 Strong                    | ≥2 supporting  
|                   |  ≥3 Moderate                 |
|                   |  2 Moderate                  | ≥2 supporting  
|                   |  1 Moderate                  |  ≥4 supporting 
| Benign            |  1 Stand-alone  
|                   |  ≥2 Strong 
| Likely benign     |1 Strong  and                 | 1 supporting  
|                   |  ≥2 Supporting 

|               | B. Strong                                                                                                 | B. Supporting                                                                                                                                                                                                                                                               | P. Supporting                                                                                            | P. Moderate                                                                                                                                                       | P. Strong                                                                 | P. Very strong                                                                   |
| --            | --                                                                                                        | --                                                                                                                                                                                                                                                                          | --                                                                                                       | --                                                                                                                                                                | --                                                                        | --                                                                               |
| Population    |  MAF is too high for disorder BA1/BS1 OR observation in controls inconsistent with disease penetrance BS2 |                                                                                                                                                                                                                                                                             |                                                                                                          |                                                                                                                                                                   |  Absent in population databases PM2                                       | Prevalence in affecteds statistically increased over controls PS4                |
| Computational |                                                                                                           | - Multiple lines of computational evidence suggest no impact on gene /gene product BP4 <br> - Missense in gene where only truncating cause disease BP1 <br> - Silent variant with non predicted splice impact BP7 <br> - In-frame indels in repeat w/out known function BP3 |  Multiple lines of computational evidence support a deleterious effect on the gene /gene product PP3     | - Novel missense change at an amino acid residue where a different pathogenic missense change has been seen before PM5 <br> - Protein length changing variant PM4 | Same amino acid change as an established pathogenic variant PS1           | Predicted null variant in a gene where LOF is a known mechanism of disease PVS1  |
| Functional    | Well-established functional studies show no deleterious effect BS3                                        |                                                                                                                                                                                                                                                                             | Missense in gene with low rate of benign missense variants and path. missenses common PP2                | Mutational hot spot or well-studied functional domain without benign variation PM1                                                                                | Well-established functional studies show a deleterious effect PS3         |                                                                                  |
| Segregation   | Nonsegregation with disease BS4                                                                           |                                                                                                                                                                                                                                                                             |  Cosegregation with disease in multiple affected family members PP1                                      | →                                                                                                                                                                 | →                                                                         | →                                                                                |
| De novo       |                                                                                                           |                                                                                                                                                                                                                                                                             |  De novo (without paternity & maternity confirmed) PM6                                                   |  De novo (paternity and maternity confirmed) PS2                                                                                                                  |                                                                           |
| Allelic data  |                                                                                                           |                                                                                                                                                                                                                                                                             | Observed in trans with a dominant variant BP2 <br> -  Observed in cis with a pathogenic variant BP2 <br> |                                                                                                                                                                   |  For recessive disorders, detected in trans with a pathogenic variant PM3 | | |
| Other         |                                                                                                           |  Reputable source w/out shared data = benign BP6                                                                                                                                                                                                                            | Reputable source = pathogenic PP5                                                                        |                                                                                                                                                                   |                                                                           |
| Other data    |                                                                                                           |  Found in case with an alternate cause BP5                                                                                                                                                                                                                                  |  Patient’s phenotype or FH highly specific for gene PP4                                                  |                                                                                                                                                                   |                                                                           |                                                                                                                                                                    |


[Source](https://www.nature.com/articles/gim201530)
